NEO Operating Cash Flow (Statement)

Neogenomics Inc · Operating Cash Flow (Statement)

NEO logo

NEO Operating Cash Flow (Statement)

Latest reported$22.05M
NEO TTM Cash from Operations (-$177.13K → $22.05M)
High-resolution chart · PNG

NEO operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Neogenomics Inc Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
22,049,000
22,420,000
5,230,000
13,687,000
14,049,000
7,611,000
7,023,000
15,007,000
264,000
-15,176,000
-1,953,000
-23,422,000
-34,197,000
-49,645,000
-65,993,000
-82,084,000
-73,579,000
-57,973,000
-26,723,000
-962,000
7,331,000
10,603,000
1,460,000
-1,166,000
16,942,000
10,339,000
23,369,000
35,463,000
25,210,000
36,571,000
44,786,000
35,092,000
34,147,000
34,035,000
18,037,000
12,037,000
14,224,000
12,975,000
21,477,000
23,839,000
16,591,000
13,996,000
6,393,000
5,258,000
6,049,000
7,638,000
9,450,000
7,959,000
6,992,000
4,582,000
2,227,000
2,733,000
25,000
-757,000
-492,000
746,000
1,139,000
548,000
69,000
-809,000
-1,618,000
-2,032,000
-2,052,000
-2,867,517
-2,455,839
-2,732,878
-1,500,417
-1,002,552
-149,283
-664,483
-138,306
-635,082
-1,596,371
-2,065,922
-2,642,591
-2,581,506
-2,005,878
-798,077
-693,782
-518,898
-644,564
-937,565
-902,051
-835,523
-856,767
-771,439
-658,133
-642,663
-529,750
-539,596
-532,366
-491,336
-440,984
-448,117
-384,796
-329,749
-303,337
-119,726
-77,407
-83,214
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.